Vita Life Sciences Limited (ASX:VLS)
Australia · Delayed Price · Currency is AUD 2.780
+0.040 (1.46%)
Aug 21, 2026, 4:10 PM AEST
Vita Life Sciences Market Cap
Vita Life Sciences has a market cap or net worth of 156.74 million as of August 21, 2026. Its market cap has increased by 28.87% in one year.
Market Cap
156.74M
Enterprise Value
125.09M
Revenue
96.03M
Ranking
n/a
PE Ratio
14.07
Stock Price
2.78
ChartMarket Cap Chart
Since August 23, 2007, Vita Life Sciences's market cap has increased from 2.18M to 156.74M, an increase of 7,081.02%. That is a compound annual growth rate of 25.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 156.74M | 11.23% |
| Dec 31, 2025 | 140.92M | 26.53% |
| Dec 31, 2024 | 111.37M | 16.19% |
| Dec 27, 2023 | 95.85M | 25.15% |
| Dec 21, 2022 | 76.59M | -26.95% |
| Dec 31, 2021 | 104.86M | 93.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Little Green Pharma | 60.44M |
| Medical Developments International | 58.02M |
| Syntara | 52.97M |
| Peak Processing | 20.60M |
| IDT Australia | 17.52M |
| Vitura Health | 16.57M |
| Epsilon Healthcare | 10.12M |
| Percheron Therapeutics | 8.37M |